Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation
Condition(s):Endometrial ReceptivityLast Updated:February 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Endometrial ReceptivityLast Updated:February 28, 2024Recruiting
Condition(s):Perinatal DisorderLast Updated:February 28, 2024Recruiting
Condition(s):Asherman Syndrome; Endometrial AtrophyLast Updated:February 28, 2024Recruiting
Condition(s):Oligospermia; DNA Damage; IVF; ICSI; EmbryoLast Updated:March 7, 2024Recruiting
Condition(s):Male InfertilityLast Updated:March 5, 2024Recruiting
Condition(s):Premature Ovarian InsufficiencyLast Updated:February 28, 2024Completed
Condition(s):Size of the Uterine FibroidsLast Updated:March 5, 2024Recruiting
Condition(s):Asherman Syndrome; Endometrial AtrophyLast Updated:March 5, 2024Recruiting
Condition(s):Donor Site ComplicationLast Updated:February 12, 2020Terminated
Condition(s):Pregnancy Loss, EarlyLast Updated:September 23, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.